RxDoctor Payments Data

Benjamin Neff, DO

Family Medicine · Salt Lake City, UTNPI 1386106060

Payments from drug & device makers

$6,097in general payments, 2019–2025

Across 325 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$425
  • Amgen$406
  • Pfizer$396
  • Viiv Healthcare Company$390
  • Astellas Pharma US Inc$289
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$5,99798%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,097 in reported general payments places this provider in the 85th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$105,392
Medicare patients
209
Services billed
1,292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin106$129,346
OzempicSemaglutide112$112,819
MounjaroTirzepatide92$106,898
EliquisApixaban56$55,690
FarxigaDapagliflozin Propanediol38$38,210
MyrbetriqMirabegron30$33,159
Repatha SureclickEvolocumab18$10,187
XareltoRivaroxaban12$9,726
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,840
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl54$7,531
ArexvyRsvpref3 Antigen/As01e/Pf23$7,192
ShingrixVaricella-Zoster Ge/As01b/Pf21$4,653
Gabapentin169$4,046
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen147$4,037
Levothyroxine Sodium284$3,772

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$282$129,346106 claims
Novo NordiskOzempic$125$112,819112 claims
Lilly USA, LLCMounjaro$425$106,89892 claims
PfizerEliquis$396$55,69056 claims
AstraZenecaFarxiga, Breztri Aerosphere$95$46,04950 claims
Astellas Pharma US IncMyrbetriq$289$33,15930 claims
GSKArexvy, Shingrix$217$11,84544 claims
Johnson & JohnsonXarelto$123$9,72612 claims
AbbVieSynthroid$1,531$1,37323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 928 family medicine providers in Utah.

Other family medicine in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →